Cas no 377769-39-6 (N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide)
N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide Chemical and Physical Properties
Names and Identifiers
-
- N-(4-Hydrazinocarbonyl-benzyl)-4,N-dimethyl-benzenesulfonamide
- N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide
- Z57969079
- N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide
- EN300-03678
- Oprea1_776835
- CS-0219312
- N-[[4-(hydrazinecarbonyl)phenyl]methyl]-N,4-dimethylbenzenesulfonamide
- 377769-39-6
- AKOS000116260
- G34626
- N-{[4-(HYDRAZINECARBONYL)PHENYL]METHYL}-N,4-DIMETHYLBENZENESULFONAMIDE
-
- Inchi: 1S/C16H19N3O3S/c1-12-3-9-15(10-4-12)23(21,22)19(2)11-13-5-7-14(8-6-13)16(20)18-17/h3-10H,11,17H2,1-2H3,(H,18,20)
- InChI Key: JERDRLBWANWUAX-UHFFFAOYSA-N
- SMILES: S(C1C=CC(C)=CC=1)(N(C)CC1C=CC(C(NN)=O)=CC=1)(=O)=O
Computed Properties
- Exact Mass: 333.11471265Da
- Monoisotopic Mass: 333.11471265Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 23
- Rotatable Bond Count: 5
- Complexity: 487
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.5
- Topological Polar Surface Area: 101?2
N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1289982-50mg |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 95% | 50mg |
¥1728.00 | 2024-05-16 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1289982-100mg |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 95% | 100mg |
¥1782.00 | 2024-05-16 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1289982-250mg |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 95% | 250mg |
¥1987.00 | 2024-05-16 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1289982-500mg |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 95% | 500mg |
¥4404.00 | 2024-05-16 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1289982-1g |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 95% | 1g |
¥6451.00 | 2024-05-16 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1289982-2.5g |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 95% | 2.5g |
¥11765.00 | 2024-05-16 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1289982-5g |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 95% | 5g |
¥20055.00 | 2024-05-16 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1289982-10g |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 95% | 10g |
¥25758.00 | 2024-05-16 | |
| Enamine | EN300-03678-0.05g |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 98% | 0.05g |
$64.0 | 2023-06-18 | |
| Enamine | EN300-03678-0.1g |
N-{[4-(hydrazinecarbonyl)phenyl]methyl}-N,4-dimethylbenzene-1-sulfonamide |
377769-39-6 | 98% | 0.1g |
$66.0 | 2023-06-18 |
N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide Related Literature
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
Additional information on N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide
N-{4-(Hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide (CAS No. 377769-39-6): A Comprehensive Overview
N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide (CAS No. 377769-39-6) is a specialized organic compound with a unique molecular structure that combines sulfonamide and hydrazine functional groups. This compound has garnered attention in recent years due to its potential applications in pharmaceutical research and material science. The presence of both hydrazinecarbonyl and sulfonamide moieties makes it a versatile intermediate for synthesizing more complex molecules.
The chemical structure of N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide features a benzene ring substituted with a dimethyl sulfonamide group and a hydrazine-linked carbonylphenylmethyl side chain. This arrangement provides the compound with distinct physicochemical properties, including moderate solubility in polar organic solvents and stability under controlled conditions. Researchers have explored its reactivity, particularly in the context of amide bond formation and sulfonamide-based transformations, which are crucial in medicinal chemistry.
One of the most significant applications of CAS 377769-39-6 lies in its role as a building block for drug discovery. The sulfonamide group is a common pharmacophore found in many FDA-approved drugs, known for its ability to enhance bioavailability and target specificity. Meanwhile, the hydrazinecarbonyl functionality offers opportunities for further derivatization, making this compound valuable for designing novel enzyme inhibitors or receptor modulators. Recent studies have investigated its potential in developing treatments for metabolic disorders and inflammatory conditions, aligning with current trends in precision medicine.
In material science, N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide has shown promise as a precursor for functional polymers. Its ability to form stable hydrogen bonds and participate in cross-linking reactions makes it suitable for creating advanced materials with tailored properties. Researchers are particularly interested in its application for smart coatings and responsive hydrogels, which are gaining traction in industries ranging from biomedical devices to environmental remediation.
The synthesis of CAS 377769-39-6 typically involves multi-step organic reactions, starting from commercially available precursors. Key steps often include the protection of functional groups, controlled coupling reactions, and careful purification to ensure high purity. Analytical techniques such as HPLC, NMR spectroscopy, and mass spectrometry are essential for characterizing this compound and verifying its structural integrity. These quality control measures are critical, especially when the compound is intended for research applications where consistency is paramount.
From a commercial perspective, the demand for N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide has been steadily increasing, particularly from pharmaceutical and specialty chemical companies. Suppliers often highlight its high purity grade (typically ≥95%) and provide detailed technical data sheets to facilitate research use. The compound is generally offered in small to medium quantities, catering to the needs of laboratory-scale investigations and process development studies.
Safety considerations for handling CAS 377769-39-6 follow standard laboratory protocols for organic compounds. While not classified as highly hazardous, appropriate personal protective equipment (PPE) including gloves and safety glasses is recommended. Proper storage conditions (typically cool, dry environments away from strong oxidizers) help maintain the compound's stability over extended periods. These precautions align with the growing emphasis on green chemistry principles and workplace safety standards in research environments.
Looking ahead, the scientific community continues to explore new applications for N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide. Emerging research areas include its potential use in bioconjugation chemistry and as a linker molecule in drug delivery systems. The compound's unique structural features make it particularly interesting for developing targeted therapies, a key focus area in contemporary pharmaceutical research. Additionally, its application in creating functionalized surfaces for biosensors represents another promising direction that aligns with current interests in diagnostic technologies.
For researchers working with CAS 377769-39-6, access to reliable characterization data is essential. Many scientific databases now include detailed information about this compound's spectral properties, solubility characteristics, and thermal stability. This information facilitates its integration into various research workflows, from initial discovery phases to optimization studies. The availability of such comprehensive data reflects the compound's growing importance in chemical research and its potential to contribute to significant scientific advancements.
In conclusion, N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide (CAS No. 377769-39-6) represents a valuable chemical entity with diverse applications across multiple scientific disciplines. Its unique combination of functional groups offers numerous possibilities for molecular design and innovation. As research continues to uncover new uses for this compound, its role in advancing both pharmaceutical development and materials science is likely to expand further, making it a compound worth watching in the coming years.
377769-39-6 (N-{4-(hydrazinecarbonyl)phenylmethyl}-N,4-dimethylbenzene-1-sulfonamide) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)